Search the Newsreel

Form 8K Shattuck Labs Inc For: 11 August By Investing.com

This article announces that Shattuck Labs Inc. filed a Form 8K on August 11, according to Investing.com. The brief news item includes the company's stock symbol STTK and its positive performance for the day. No further details about the content of the Form 8K …

MOBIX LABS, INC. (MOBX) Earnings Forecast: Future EPS & Revenue Growth Estimates

GeoVax targets Q4 phase 3 trial for MVA mpox vaccine with EMA expedited pathway

GeoVax Labs Inc. is preparing to initiate a pivotal phase 3 trial for its GEO-MVA mpox and smallpox vaccine candidate by the end of 2024, following an expedited regulatory pathway granted by the European Medicines Agency (EMA). The EMA waived phase 1 and 2 …

Jyothy Labs Q1 Results: Net Profit Slumps 51% As Margin Shrinks, Revenue Up 3% YoY; Stock Falls 4%

Lyka Labs standalone profit surges 159% in Q1FY27 on export strength

VivoSim Labs Ord Shs (VIVS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for VivoSim Labs Ord Shs (VIVS), detailing its current stock performance, market capitalization, and P/E ratio. It also lists peer comparisons with other biotechnology and medical research companies, indicating the number of ratings and analysts for each. The …

Is Shattuck Labs Inc (STTK) Overvalued Following Q2 Earnings Mis

Proto Labs (PRLB) Is Up 11.7% After Raising 2026 Revenue Guidance And Highlighting Rising Customer Spend

In late July 2026, Proto Labs, Inc. reported past second-quarter results showing sales of US$149.34 million and net income of US$9.15 million, alongside raising its full-year 2026 revenue growth guidance to 8%–10% and issuing new third-quarter earnings guidance. Management highlighted a 17% year-over-year increase …

Shattuck Labs, Inc. Stock 12‑Month Price Target Cut to $14.86, Implies 108% Upside

Analysts have lowered the average 12-month price target for Shattuck Labs, Inc. (STTK) stock from $15 to $14.86, implying a potential upside of 108% based on the August 10 closing price. Despite the reduction, the consensus rating from 9 covering analysts remains a "Buy," …

STTK Maintained by HC Wainwright & Co. -- Price Target Lowered to $14

HC Wainwright & Co. has maintained a 'Buy' rating for Shattuck Labs (STTK) but lowered its price target from $18.00 to $14.00, reflecting a cautious outlook due to the company's significant overvaluation, low profitability, and mixed insider sentiment. Despite developing innovative therapies, the stock …

HC Wainwright Cuts Shattuck Labs (NASDAQ:STTK) Price Target to $14.00

HC Wainwright has reduced its price target for Shattuck Labs (NASDAQ:STTK) to $14.00 from $18.00, while maintaining a "buy" rating, indicating a potential upside of approximately 94%. Despite the lowered target, analysts collectively give the company a "Moderate Buy" rating with an average target …

Astera Labs Posted 104% Revenue Growth in Q2. Why Is ALAB Down From Its Highs?

Astera Labs (ALAB) reported strong Q2 revenue growth of 104% year-over-year, beating analyst expectations, and provided optimistic Q3 guidance. Despite this strong performance and raised analyst targets, the stock is down from its highs, trading at a high valuation multiple. The company's growth drivers …

Shattuck Labs 2Q Loss/Shr 12c >STTK

Shattuck Labs (STTK) reported a second-quarter loss per share of 12 cents. Further details regarding their financial performance were not provided in this brief announcement.

Astera Labs Inc (Derivatives): Latest News, Social Media Updates and Insights

This article provides the latest news and social media updates for Astera Labs Inc (Derivatives). It highlights that 12 Nasdaq 100 stocks, including Sandisk, have more than doubled in 2026, with none of them being part of the "Magnificent Seven" group. The article also …

Astera Labs, Inc. (ALAB) Stock Price, News, Quote & History

This page provides a comprehensive overview of Astera Labs, Inc. (ALAB) stock, including its current price, historical data, key financial metrics, and analyst insights. The stock closed at $311.99 on August 11, with pre-market trading showing a rise to $318.03. Astera Labs specializes in …

Can MRVL's NVDA Alliance Help it Challenge ALAB & AVGO?

Marvell Technology MRVL and NVIDIA NVDA are collaborating on advanced networking and optical technologies. Their expanded partnership includes silicon photonics and advanced optical interconnect solutions, areas in which MRVL has established capabilities in optical DSPs, silicon photonics and high-speed connectivity, and NVIDIA has NVLink …

Shattuck Labs (NASDAQ:STTK) Releases Earnings Results, Hits Expectations

Australian Clinical Labs Limited (ASX:ACL) Share Market Overview and Healthcare Sector Profile

Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases

Shattuck Labs has released an investor deck detailing its strategy to develop DR3-blocking antibodies, primarily SL-325, for inflammatory and immune-mediated diseases. A Phase 2b trial for SL-325 in Crohn's disease is set to begin in Q3 2026, with initial data expected in 1H 2028. …

GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase

GeoVax is highlighting its Gedeptin(R) therapy as a tumor-priming strategy following the FDA's accelerated approval of Replimune's intratumoral therapy TUDRIQEV in combination with nivolumab. GeoVax believes this approval reinforces the paradigm that local tumor destruction can enhance immune responses, an area where Gedeptin, a …

Astera Labs vs. Arm: Which Technology Stock Is a Better Buy in 2026?

As artificial intelligence demands higher performance, investors are weighing the explosive growth of Astera Labs (NASDAQ:ALAB) against the architectural dominance of Arm (NASDAQ:ARM) to find the superior long-term play. While both companies are essential to the modern computing ecosystem, they occupy different niches. Astera …

Shattuck Labs Reports $15.2 Million Q2 Loss and 2029 Cash Runway

Shattuck Labs (STTK) reported a Q2 2026 net loss of $15.2 million, with $0 revenue, and expects its $208.3 million in cash to fund operations into 2029. The company provided updates on its SL-325 clinical trial, with Phase 2b starting in Q3 2026, and …

Shattuck Labs GAAP EPS of -$0.12 in-line

* Shattuck Labs press release [https://seekingalpha.com/pr/20614116-shattuck-labs-reports-second-quarter-2026-financial-results-and-recent-business-highlights] (STTK [https://seekingalpha.com/symbol/STTK]): Q2 GAAP EPS of -$0.12 in-line. * As of June 30, 2026, cash and cash equivalents, and short-term investments, were approximately $208.3 million. Shattuck’s current cash and cash equivalents, and short-term investments are expected to fund …

Aarti Pharmalabs Hits ₹868 Bull Target; Gains 15.6%

Renaissance Technologies LLC Buys 120,188 Shares of BioAge Labs, Inc. $BIOA

Renaissance Technologies LLC significantly increased its stake in BioAge Labs, Inc. (NASDAQ:BIOA) by 653.2% in the first quarter, acquiring an additional 120,188 shares, bringing its total to 138,588 shares valued at approximately $2.42 million. Other institutional investors also added to their positions. Despite reporting …

Mobix Labs Inc. Class A (MOBX) Live Share Price, Invest From India

This article provides a detailed financial overview of Mobix Labs Inc. Class A (MOBX), including its live share price, performance metrics, historical returns, fundamentals, and peer comparisons. It also outlines how Indian investors can invest in MOBX shares through the INDmoney app, detailing investment …

AARTIPHARM Standalone June 2026 Net Sales at Rs 534.59 crore, up 42.44% Y-o-Y

Establishment Labs Holdings Inc. $ESTA Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly increased its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 164.9% in the second quarter, now owning 135,897 shares valued at $11.66 million. Other institutional investors also adjusted their positions in the company. Establishment Labs' stock opened at $75.06, …

Half Yearly Results, Half yearly Earnings for Lyka Labs

Shattuck Labs Releases Q2 2026 10-Q Filing Highlighting Key Risk Factors and Share Count

Shattuck Labs, Inc. has filed its Form 10-Q for the second quarter of 2026 with the SEC, making the report available on August 11, 2026. This filing highlights key risk factors and provides an update on the company's share count. Readers can access the …

Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?

Quantum X Labs Piles Up Technical Milestones as Investors Weigh 2027 Qubit Ambitions

Quantum X Labs, the quantum computing arm of Gix Internet, has announced several technical advancements in nuclear simulations, clinical AI, and error correction, leading to significant stock volatility. The company aims to scale its neutral-atom platform to several thousand qubits by the first half …

Jane Street Group discloses 4.3% GeoVax Labs (GOVX) ownership in updated 13G

Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC, has filed an amended Schedule 13G disclosing a 4.3% beneficial ownership in GeoVax Labs, Inc. (GOVX). This stake amounts to 315,275 shares of common stock, with …

Astera Labs (ALAB) director Stefan Dyckerhoff sells 12,499 shares under 10b5-1 plan

Astera Labs director Stefan A. Dyckerhoff sold 12,499 shares of common stock on August 6, 2026, through multiple open-market transactions. These sales were conducted at weighted average prices between $309 and $313 per share, according to a Rule 10b5-1 trading plan established on December …

Blend Labs, Inc.'s (NYSE:BLND) Shift From Loss To Profit

What Makes Proto Labs (PRLB) a Strong Momentum Stock: Buy Now?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …